TABS represents an addition to the literature in its ability to capture a more nuanced conceptualization of transgender attitude not found in previous scales.

Even though adaption of the Voodoo Floss Band is gaining momentum, evidence-based literature on its effectiveness remains sparse. The purpose of this quantitative observational design study was to investigate the effects of the Voodoo Floss Band on soft-tissue flexibility and perception of movement. A repeated-measures ANOVA with between-subjects factor demonstrated both groups significantly improved GH flexion range of motion from pretest to post-test but there was not a statistically significant difference between the groups. Perceptions of flexibility increased more for the Voodoo Floss Band group, demonstrating a psychological increase in GH flexion, but not a physical increase.

Background: Evidence-based practice supports the use of validated outcome measures to assess the effect of lymphedema; however, condition-specific lymphedema assessment measures are needed. The Lymphedema Life Impact Scale (LLIS) has been validated as a comprehensive lymphedema-specific instrument to assess the effects of lymphedema in any extremity. Objectives: This multicenter, cross-sectional study investigated the reliability and validity of a revised version of the LLIS, known as LLIS version 2. Methods: Qualifying patients from lymphedema clinics across the United States completed self-report outcome measures; clinicians measured limb circumference. Test-retest reliability was assessed in a subgroup of 21 participants. Internal consistency and validity were assessed in 84 participants with upper- or lower-limb lymphedema. Results: Intraclass correlation coefficients for test-retest reliability ranged from 0.687 to 0.895. Cronbach α coefficients for internal consistency ranged between 0.847 and 0.953. Construct validity of the LLIS was upheld with symptoms but not with edema severity. The LLIS correlated from moderately to highly with most domains of the comparator LYMQOL (Lymphedema Quality of Life scale) used in this study. Minimal clinically important difference of the LLIS was 7.27; MDC95 was 12.74. Limitations: Despite adequate group sizes, the vast majority of participants were white females, so generalizations to male patients or to those of different races should be done cautiously. Conclusions: LLIS version 2 is a valid and reliable tool for the assessment of severity of impairment among patients with lymphedema.

No abstract

Excellent outcomes have been reported following thyroidectomy for thyroid carcinoma in dogs, but outcomes for thyroid carcinomas with gross vascular invasion are poorly described. This study describes the clinical outcomes and complications in dogs with thyroid carcinomas with gross vascular invasion undergoing thyroidectomy. Medical records of dogs that underwent thyroidectomy between January 1st 2010 and December 31st 2019 were reviewed at 10 hospitals. Signalment, diagnostic data, primary and adjuvant treatments performed, and outcome were abstracted. Survival was calculated using Kaplan–Meier analysis. Multiple logistic regression was used to identify variables associated with disease‐specific survival. Seventy‐three dogs were included, of which 58 underwent unilateral thyroidectomy and 15 underwent bilateral thyroidectomy. Complications were reported in five dogs (three major, two minor; 6.8%) intraoperatively and 12 dogs (two major leading to death, 10 minor; 16.4%) postoperatively. Seven (9.6%) dogs developed locoregional recurrence at a median of 238 days postoperatively (range: 15–730 days). Distant metastasis was suspected or confirmed in nine dogs (12.3%) at a median of 375 days postoperatively (range: 50–890 days). Twenty‐seven dogs (37%) received adjuvant therapy (chemotherapy: n = 21; radiotherapy: n = 6). Thirty‐nine dogs were euthanized or died, with 20 deaths related to disease (n = 10) or of unknown cause (n = 10), 19 due to unrelated causes, and nine lost to follow‐up. Median overall and disease‐specific survival were 621 days and not reached respectively. One‐year disease‐specific survival rate was 82.5%. No variables were associated with disease‐specific survival in our dataset. Surgery may be considered for loco‐regional therapy in dogs with thyroid carcinoma with gross vascular invasion.